Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Adverse effects | |||||
RCT Crossover design 3-armed trial |
25 people aged 70 to 89 years with primary insomnia; 20 people completed at least 1 treatment arm |
Total number of adverse events
14 days
90 with diphenhydramine 50 mg for 14 nights 90 with placebo |
P value not reported Reported as not significant |
Not significant |